Showing results (1-10 of 548) with videos related to
Sort By:
Pageof 55
Nature Reviews. Microbiology|August 22, 2022
Anti-trypanosomatid drug discovery: progress and challengesManu De Rycker, Susan Wyllie, David Horn, et al.Nature Reviews. Microbiology|February 28, 2017
Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing needMark C Field, David Horn, Alan H Fairlamb, et al.Nature Reviews. Microbiology|September 13, 2018
Author Correction: Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing needMark C Field, David Horn, Alan H Fairlamb, et al.Plos Neglected Tropical Diseases|October 11, 2021
Live-imaging rate-of-kill compound profiling for Chagas disease drug discovery with a new automated high-content assayNina Svensen, Susan Wyllie, David W Gray, et al.Nature|July 27, 2018
Challenges and recent progress in drug discovery for tropical diseasesManu De Rycker, Beatriz Baragaña, Suzanne L Duce, et al.Antimicrobial Agents and Chemotherapy|July 17, 2013
The R enantiomer of the antitubercular drug PA-824 as a potential oral treatment for visceral LeishmaniasisStephen Patterson, Susan Wyllie, Laste Stojanovski, et al.Bioorganic & Medicinal Chemistry Letters|August 15, 2018
2,4-Diamino-6-methylpyrimidines for the potential treatment of Chagas' diseaseMichael G Thomas, Manu De Rycker, Ignacio Cotillo Torrejon, et al.ACS Infectious Diseases|November 2, 2018
Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovaniVictoriano Corpas-Lopez, Sonia Moniz, Michael Thomas, et al.Antimicrobial Agents and Chemotherapy|April 11, 2013
Comparison of a high-throughput high-content intracellular Leishmania donovani assay with an axenic amastigote assayManu De Rycker, Irene Hallyburton, John Thomas, et al.Plos One|June 1, 2019
Identification of inhibitors of an unconventional Trypanosoma brucei kinetochore kinaseLeah S Torrie, Fabio Zuccotto, David A Robinson, et al.Pageof 55